Nephron Starts Tandem Diabetes Care (TNDM) at Buy
Get Alerts TNDM Hot Sheet
Price: $35.56 +1.25%
Rating Summary:
16 Buy, 8 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
16 Buy, 8 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Nephron analyst Chris Pasquale initiates coverage on Tandem Diabetes Care (NASDAQ: TNDM) with a Buy rating and a price target of $95.00.
For an analyst ratings summary and ratings history on Tandem Diabetes Care click here. For more ratings news on Tandem Diabetes Care click here.
Shares of Tandem Diabetes Care closed at $56.73 yesterday.
You May Also Be Interested In
- Leerink Partners Upgrades Tandem Diabetes Care (TNDM) to Outperform
- Scotiabank Starts Rapid7 (RPD) at Sector Perform
- Goldman Sachs Resumes Dada Nexus Ltd. (DADA) at Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!